Sertraline in the treatment of Alzheimer’s disease-related depression Thomas W. McAllister Clinical Trials Report Pages: 353 - 353
Efficacy of divalproex in adolescents with explosive temper and mood instability Thomas W. McAllister Clinical Trials Report Pages: 353 - 354
Impact of molecular medicine on neuropsychiatry: The clinician’s perspective J. Michael RyanRebekah LoyPierre N. Tariot OriginalPaper Pages: 355 - 360
Autism spectrum disorders: Update of evaluation and treatment Ashraf G. MikhailBryan H. King OriginalPaper Pages: 361 - 365
Deep brain stimulation in neuropsychiatric disorders Robert M. RothLaura A. FlashmanDavid W. Roberts OriginalPaper Pages: 366 - 372
The neuropsychology of multiple sclerosis: Contributions of neuroimaging research Heather A. WishartLaura FlashmanAndrew J. Saykin OriginalPaper Pages: 373 - 378
An overview of psychiatric symptoms in Huntington’s disease Karen E. AndersonKaren S. Marder OriginalPaper Pages: 379 - 388
Rehospitalization rates and antipsychotic medications Stephen R. Marder Clinical Trials Report Pages: 391 - 392
Treatment-refractory schizophrenia Peter F. BuckleyLisa D. WigginsBeth Singer OriginalPaper Pages: 393 - 400
The challenge of psychiatric rehabilitation in schizophrenia Shirley M. Glynn OriginalPaper Pages: 401 - 406
Psychosocial treatments for schizophrenia Alan S. BellackSeth A. Brown OriginalPaper Pages: 407 - 412
Managing comorbid schizophrenia and substance abuse Robert E. DrakeKim T. Mueser OriginalPaper Pages: 418 - 422
Cognition in schizophrenia Philip D. HarveyChristopher R. BowieJoseph I. Friedman OriginalPaper Pages: 423 - 428